Standardize the diagnosis and treatment of drug-induced liver injury, and strengthen clinical and translational research / 中华肝脏病杂志
Chinese Journal of Hepatology
; (12): 337-338, 2023.
Article
em Zh
| WPRIM
| ID: wpr-986138
Biblioteca responsável:
WPRO
ABSTRACT
As a liver disease with the most complex clinical phenotype, drug-induced liver injury (DILI) poses great challenges in diagnosis and management in clinical practice. Although guidelines based on the latest research advances can provide clinicians with guidance on the identification, diagnosis, and management of DILI, the overall level of evidence in this field is relatively low and high-level evidence is limited. Therefore, we should interpret guidelines with caution and look forward to more clinical and translational research to address the huge unmet clinical needs in DILI.
Palavras-chave
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Doença Hepática Induzida por Substâncias e Drogas
/
Pesquisa Translacional Biomédica
/
Hepatopatias
/
Testes de Função Hepática
Limite:
Humans
Idioma:
Zh
Revista:
Chinese Journal of Hepatology
Ano de publicação:
2023
Tipo de documento:
Article